The manufacturing of biological pharmaceuticals presents unique challenges due to the sensitive nature of biological materials and the stringent requirements for sterility and containment. Dow Engifab provides specialized solutions designed specifically for biological pharmaceutical processing
Biological Material Handling
Specialized containment systems for the safe handling of biological materials, including cell cultures, viral vectors, and other biological entities. These systems maintain both product integrity and operator safety.
Sterile Processing
Isolator systems designed specifically for sterile processing of biological pharmaceuticals, incorporating advanced sterilization technologies and aseptic handling capabilities.
Biosafety Considerations
Equipment designed with biosafety principles in mind, providing appropriate containment levels for various biological agents according to biosafety classification requirements.
Dow Engifab's biological solutions integrate containment technology with sterility requirements, creating systems that protect both the product from contamination and the environment from potential biological hazards. These solutions are particularly valuable for manufacturers working with vaccines, cell therapies, gene therapies, and other advanced biological products.
The company's expertise in both containment and sterile technologies allows for the development of customized solutions that address the specific challenges of biological pharmaceutical manufacturing, from research scale to commercial production
